Completion of AffinityDNA Acquisition

Melbourne, Australia, 14 July 2022:Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease is delighted to announce that it has completed the acquisition of the direct-to-consumer eCommerce business and 1 Acquisition Highlights: • Strategic acquisition strengthens the direct-to-consumer channel for GTG